SureTrader Advertisement PRTC
Home > Boards > US Listed > Biotechs >

Enanta Pharmaceuticals (ENTA)

ENTA RSS Feed
Add ENTA Price Alert      Hide Sticky   Hide Intro
Moderator: DewDiligence
Search This Board:
Last Post: 5/1/2016 1:36:39 PM - Followers: 64 - Board type: Free - Posts Today: 0
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
ENTA
Current Price
Volume:
Bid Ask Day's Range
Wiki
SureTrader
ENTA News: Enanta Pharmaceuticals to Host Conference Call on May 9 at 4:30 p.m. ET to Discuss Financial Results for its Fiscal Second Qu... 04/27/2016 04:05:00 PM
ENTA News: Enanta Pharmaceuticals to Present at the Deutsche Bank 41st Annual Healthcare Conference Presentation to be Webcast on May 4,... 04/26/2016 08:00:00 AM
ENTA News: Enanta Announces U.S. FDA has Approved AbbVie’s Supplemental New Drug Application for Use of VIEKIRA PAK® without Ribaviri... 04/25/2016 09:10:00 AM
ENTA News: AbbVie Receives U.S. FDA Approval of Supplemental New Drug Application for VIEKIRA PAK® (ombitasvir, paritaprevir, and riton... 04/25/2016 09:00:00 AM
ENTA News: Enanta Announces New Data from AbbVie’s SURVEYOR-1 & SURVEYOR-2 Studies Showing High Sustained Virologic Response Rates aft... 04/16/2016 01:10:00 AM
PostSubject
#1356  Sticky Note Global phase-3 program for ABT-493/ABT-530 (10 phase-3 trials, DewDiligence 04/19/16 03:40:30 PM
#1361   Enta, Abbvie, Gilead, post earnings release. willyw 05/01/16 01:36:39 PM
#1360   Please see #msg-122248041. DewDiligence 04/28/16 09:30:09 AM
#1359   Viekera sales: guyschmid 04/28/16 09:23:47 AM
#1358   ENTA FY2Q16 CC—5/9/16 4:30pm ET: DewDiligence 04/27/16 04:11:36 PM
#1357   V-Pak without ribavirin approved by FDA/EMA for Child DewDiligence 04/25/16 05:52:21 PM
#1356   Global phase-3 program for ABT-493/ABT-530 (10 phase-3 trials, DewDiligence 04/19/16 03:40:30 PM
#1355   Twitter poll re ABBV's priority-review voucher: DewDiligence 04/18/16 04:02:52 PM
#1354   ABT-493/ABT-530 data released today are as good as DewDiligence 04/16/16 11:28:10 AM
#1353   EASL- Real world results Abbvie 1st gen program willyw 04/15/16 09:06:13 PM
#1352   Good data, but for me the question is guyschmid 04/15/16 09:06:22 AM
#1351   Impressive ABBV/ENTA SVR rates for ABT-493/ABT-450 DewDiligence 04/15/16 08:26:46 AM
#1350   http://finance.yahoo.com/news/enanta-announces-high-svr-rates-051100649.html tmoney2555 04/14/16 01:52:13 AM
#1349   Cyclophilin data is presented tomorrow I believe tmoney2555 04/13/16 10:48:10 PM
#1348   Short interest down almost 1 million from 12/1 NY1972 04/06/16 11:19:13 AM
#1347   HIGH EFFICACY OF ABT-493 AND ABT-530 IN HCV NY1972 03/30/16 11:12:39 AM
#1346   ENTA +6% on ICL (EASL) abstracts: DewDiligence 03/30/16 10:42:54 AM
#1345   This also looks very intriguing willyw 03/16/16 11:47:55 AM
#1344   Being drawn and quartered even at average volume biotech_researcher 03/15/16 05:25:33 PM
#1343   ABT-493 + ABT-530- Geno- 3 EASL Late Breaker willyw 03/14/16 12:24:18 PM
#1342   Jay Luly exercised and held ~$530K of stock today: DewDiligence 03/09/16 07:43:09 PM
#1341   www.natap.org/2016/APASL/APASL_02.htm per table 2 they are claiming for the willyw 03/08/16 01:24:10 PM
#1340   GILD's HCV sales in Japan are running at DewDiligence 03/02/16 01:50:29 PM
#1339   Enta G-1b market in Japan: Comparisons to other Therapies willyw 03/02/16 12:51:00 PM
#1338   Positive catalysts for ENTA, possible negatives. willyw 02/26/16 11:14:28 AM
#1336   Senior Center Based Hepatitis C Screening in Baltimore NY1972 02/23/16 11:55:22 AM
#1335   Comparing Cyclophilin A and miR-122 NY1972 02/18/16 11:29:03 PM
#1334   Some notes from RGLS CC: NY1972 02/18/16 02:01:38 PM
#1333   ENTA—Small open-market purchase by independent director last Friday: DewDiligence 02/17/16 12:46:09 PM
#1332   More hypes from RGLS, never in ENTA PR NY1972 02/17/16 10:35:48 AM
#1330   ENTA—The S-8 filing is not for a public DewDiligence 02/16/16 06:16:25 PM
#1329   This Registration Statement covers an aggregate of 561,505 biotech_researcher 02/16/16 05:34:57 PM
#1326   CC-31244 is a non-nucleoside polymerase inhibitor—not the class DewDiligence 02/15/16 09:12:38 AM
#1325   CC-31244 is highly potent and active against all NY1972 02/14/16 09:07:19 PM
#1324   VL levels around the proposed clinical thresholds show NY1972 02/13/16 09:42:03 PM
#1323   Canada trying to save a few bucks with NY1972 02/12/16 07:10:43 PM
#1322   Express Scripts' Miller likes price for Merck hepatitis drug NY1972 02/12/16 06:08:32 PM
#1321   Fidelity sold a little ENTA, down to 3.93% biotech_researcher 02/12/16 12:54:41 PM
#1320   Sounds like a non sequitur. DewDiligence 02/11/16 12:51:31 PM
#1319   Shorts' most favorite analyst? NY1972 02/11/16 12:48:01 PM
#1318   Shorts got shorter, must be convinced Z = NY1972 02/09/16 11:20:11 PM
#1317   The FY1Q16 10-Q has been filed: DewDiligence 02/09/16 07:09:20 PM
#1316   I think that the focus should be on Rocky3 02/09/16 06:14:19 PM
#1315   Will Japan 2D regiment bring in 200M next NY1972 02/09/16 11:20:31 AM
#1314   The word, unfortunately in that context means unfortunately DewDiligence 02/09/16 08:33:55 AM
#1313   Luly's Unfortunate view on Merck's label: NY1972 02/08/16 11:47:06 PM
#1312   It helps that the expected tax rate in DewDiligence 02/08/16 07:49:18 PM
#1311   P/E = 5??? Rocky3 02/08/16 05:36:22 PM
#1310   ENTA FY1Q16 EPS=$1.36—cash*=$254.5: DewDiligence 02/08/16 04:34:13 PM
#1308   P/E = 5 NY1972 02/08/16 02:12:40 PM
#1307  Restored Remicade, Humira and Enbrel work by blocking an biotech_researcher 02/05/16 07:43:51 PM
PostSubject